Rebeca M. Torrente-Rodríguez

Rebeca M. Torrente-Rodríguez

Auto-generated profile, based on publicly available information

Rebeca M. Torrente-Rodríguez

Department of Analytical Chemistry, Faculty of Chemistry, University Complutense of Madrid, Plaza de Las Ciencias 2, Madrid, 28040, Spain

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2022 in Talanta
Verified
Journal Article
Open access
SGShipeng Gao
Shipeng Gao
RTRebeca M. Torrente-Rodríguez
Rebeca M. Torrente-Rodríguez
María PedreroMaría Pedrero
María Pedrero
José Manuel PingarrónJosé Manuel Pingarrón
José Manuel Pingarrón
SCSusana Campuzano
Susana Campuzano
Jose M. GuisanJose M. Guisan
Jose M. Guisan
Magnetic nanoparticles (MNPs) can be used as antibody carriers in a wide range of immunosensing applications. The conjugation chemistry for preparing antibody-MNP bionanohybrids should assure the nanoparticle's colloidal dispersity, directional conformation and high biofunctionality retention of attached antibodies. In this work, peroxidase (HRP) was selected as model target analyte, and stable antibody-MNP conjugates were prepared using polyaldehyde-dextrans as multivalent linkers, also to prevent nanoparticles agglomeration and steric shielding of non-specific proteins. Under the manipulation of the oxidation variables, MNP-conjugated antibody showed the highest Fab accessibility, of 1.32 μmol analyte per μmol antibody, corresponding to 139 μmol aldehyde per gram of nanocarrier (5 mM NaIO4, 4 h). Demonstrating anti-interference advantage up to 10% serum, colorimetric immunoassay gave a detection limit (LOD) of 300 ng mL-1, while electrochemical transduction led to a considerable (680 times) improvement, with a LOD of 0.44 ng mL-1. In addition, polyaldehyde-dextran showed priority over polycarboxylated-dextran as the multivalent antibody crosslinker for MNPs in terms of sensitivity and LOD value, while immunosensors constructed with carboxylated magnetic microbeads (HOOC-MBs) outperformed MNPs-based immunoplatforms. This work sheds light on the importance of surface chemistry (type and density of functional groups) and the dimension (nanosize vs micrometer) of magnetic carriers to conjugate antibodies with better directional orientation and improve the analytical performance of the resulting immunosensors.

30 November 2022 in Analysis & Sensing
Verified
Journal Article
Open access
SCSusana Campuzano
Susana Campuzano
María PedreroMaría Pedrero
María Pedrero
RTRebeca M. Torrente‐Rodríguez
Rebeca M. Torrente‐Rodríguez
José Manuel PingarrónJosé Manuel Pingarrón
José Manuel Pingarrón
This review delves into the titanic research efforts carried out during the last years on affinity‐based wearable electrochemical biosensors, using both natural (antibodies) and biomimetic (aptamers, peptides and molecular imprinted polymers) receptors. The rationale and application of selected representative strategies is critically discussed, ending with realistic and futuristic visions of the technical barriers, challenges and prospects in the development and adoption of these biodevices in daily routines to ensure well‐being against known, unknown and unexpected threats.

24 May 2022 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
RTRebeca M. Torrente‐Rodríguez
Rebeca M. Torrente‐Rodríguez
ACAna Montero Calle
Ana Montero Calle
CBClara San Bartolomé
Clara San Bartolomé
OCOlga Cano
Olga Cano
MVMónica Vázquez
Mónica Vázquez
SCSusana Campuzano
Susana Campuzano
The development of versatile and sensitive biotools to quantify specific SARS‐CoV‐2 immunoglobulins in SARS‐CoV‐2 infected and non‐infected individuals, built on the surface of magnetic microbeads functionalized with nucleocapsid (N) and in‐house expressed recombinant spike (S) proteins is reported. Amperometric interrogation of captured N‐ and S‐specific circulating total or individual immunoglobulin (Ig) isotypes (IgG, IgM, and IgA), subsequently labelled with HRP‐conjugated secondary antibodies, was performed at disposable single or multiplexed (8×) screen‐printed electrodes using the HQ/HRP/H2O2 system. The obtained results using N and in‐house expressed S ectodomains of five SARS‐CoV‐2 variants of concern (including the latest Delta and Omicron) allow identification of vulnerable populations from those with natural or acquired immunity, monitoring of infection, evaluation of vaccine efficiency, and even identification of the variant responsible for the infection.

30 January 2024 in Sensors & Diagnostics
Verified
Journal Article
Open access
PDF file
STSandra Tejerina-Miranda
Sandra Tejerina-Miranda
VPVíctor Pérez-Ginés
Víctor Pérez-Ginés
RTRebeca M. Torrente-Rodríguez
Rebeca M. Torrente-Rodríguez
María PedreroMaría Pedrero
María Pedrero
AMAna Montero-Calle
Ana Montero-Calle
SCSusana Campuzano
Susana Campuzano
Novel amperometric immunoplatform using magnetic micro-supports and screen-printed carbon electrodes, overcoming limitations of the reported methods, to assess the senescence-associated GDF-15 marker in diagnosis and prognosis of colorectal cancer.

22 December 2023 in ChemElectroChem
Verified
Journal Article
Open access
MBMarina Blázquez‐García
Marina Blázquez‐García
Jennifer QuinchiaJennifer Quinchia
Jennifer Quinchia
VMVíctor Ruiz‐Valdepeñas Montiel
Víctor Ruiz‐Valdepeñas Montiel
RTRebeca M. Torrente‐Rodríguez
Rebeca M. Torrente‐Rodríguez
VSVerónica Serafín
Verónica Serafín
SCSusana Campuzano
Susana Campuzano
Tumor‐associated stroma biomarkers are emerging as key signaling molecules of metastasis in colorectal cancer (CRC). In this sense, periostin (POSTN), a protein of the extracellular matrix from the stromal compartment, is envisioned as a potential stromal prognostic biomarker, which facilitates the application of pertinent treatments. In this work, we report an easy‐to‐handle amperometric sandwich‐based immunosensing strategy for the determination of POSTN involving commercial magnetic microparticles (MBs), disposable carbon electrodes, and the horseradish peroxidase (HRP)/H2O2/hydroquinone (HQ) electrochemical system. The method allowed a dynamic linear range between 0.47 and 25 ng mL−1 and a limit of detection, LOD, of 0.14 ng mL−1 compatible with clinical demands. The method was applied to the analysis of POSTN in a variety of cancer‐related real bio‐scenarios including cell extracts and secretomes from CRC cells, and plasma from CRC patients at different stages. The potentials of this firstly developed MBs‐assisted immunoplatform are justified by distinguishing between metastatic abilities of cultured CRC cells through the analysis of their extracts and secretomes, and by differentiating between healthy controls and CRC patients in just 60 min. Therefore, the developed immunoplatform can be envisaged as a novel and profitable tool for exploring the most uncharacterized but prospective tumor areas.

24 May 2022 in Angewandte Chemie
Verified
Journal Article
Open access
RTRebeca M. Torrente‐Rodríguez
Rebeca M. Torrente‐Rodríguez
ACAna Montero Calle
Ana Montero Calle
CBClara San Bartolomé
Clara San Bartolomé
OCOlga Cano
Olga Cano
MVMónica Vázquez
Mónica Vázquez
SCSusana Campuzano
Susana Campuzano
The development of versatile and sensitive biotools to quantify specific SARS‐CoV‐2 immunoglobulins in SARS‐CoV‐2 infected and non‐infected individuals, built on the surface of magnetic microbeads functionalized with nucleocapsid (N) and in‐house expressed recombinant spike (S) proteins is reported. Amperometric interrogation of captured N‐ and S‐specific circulating total or individual immunoglobulin (Ig) isotypes (IgG, IgM, and IgA), subsequently labelled with HRP‐conjugated secondary antibodies, was performed at disposable single or multiplexed (8×) screen‐printed electrodes using the HQ/HRP/H2O2 system. The obtained results using N and in‐house expressed S ectodomains of five SARS‐CoV‐2 variants of concern (including the latest Delta and Omicron) allow identification of vulnerable populations from those with natural or acquired immunity, monitoring of infection, evaluation of vaccine efficiency, and even identification of the variant responsible for the infection.